Worth Venture Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,824
Closed -$398K 149
2020
Q4
$398K Sell
2,824
-2,297
-45% -$294K 0.32% 65
2020
Q3
$571K Buy
5,121
+206
+4% +$23.1K 0.48% 53
2020
Q2
$550K Sell
4,915
-2,129
-30% -$210K 0.28% 61
2020
Q1
$545K Buy
7,044
+972
+16% +$86.1K 0.35% 44
2019
Q4
$578K Buy
6,072
+187
+3% +$16.2K 0.29% 46
2019
Q3
$449K Sell
5,885
-3,306
-36% -$275K 0.26% 47
2019
Q2
$806K Buy
9,191
+1,398
+18% +$119K 0.45% 31
2019
Q1
$705K Sell
7,793
-201
-3% -$17.1K 0.4% 33
2018
Q4
$573K Buy
7,994
+2,178
+37% +$175K 0.45% 39
2018
Q3
$558K Sell
5,816
-89
-2% -$8.63K 0.43% 35
2018
Q2
$562K Sell
5,905
-1,313
-18% -$121K 0.48% 31
2018
Q1
$633K Sell
7,218
-134
-2% -$12.2K 0.58% 39
2017
Q4
$624K Sell
7,352
-966
-12% -$80.9K 0.73% 40
2017
Q3
$720K Sell
8,318
-2,916
-26% -$234K 0.64% 33
2017
Q2
$867K Sell
11,234
-2,058
-15% -$146K 0.78% 27
2017
Q1
$922K Buy
+13,292
New +$893K 0.84% 23

Other funds holding XBI